Wilson Sonsini Goodrich & Rosati has advised InduPro on the transaction. InduPro, Inc., a biotechnology company focused on developing novel therapeutics for cancer and autoimmune diseases,...
InduPro Secures $77 Million in Series B Financing for Oncology and Autoimmune Pipeline Advancement
Aqtual Raises $31 Million in Series B Financing
Wilson Sonsini Goodrich & Rosati has advised Aqtual on the deal. Aqtual, a precision medicine company based in Hayward, California, has completed a $31 million Series...
Glycomine’s $115 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised Glycomine on the transaction. Glycomine, a biotechnology company focused on developing transformative new therapies for orphan diseases, announced a $115...
GI Windows Surgical’s $37 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised GI Windows Surgical on the transaction. Massachusetts-based GI Windows Surgical, a clinical-stage medical device company dedicated to developing the first...
Illumina’s Acquisition of Fluent BioSciences
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
Bakkt’s Common Stock Offerings
Wilson Sonsini Goodrich & Rosati advised Bakkt Holdings, Inc. on the transaction, and Goodwin Procter advised the placement agent. Bakkt Holdings, Inc. (Bakkt) (NYSE: BKKT), a...
United Therapeutics’ Acquisition of IVIVA
Wilson Sonsini Goodrich & Rosati represented IVIVA in the transaction. United Therapeutics (Nasdaq:UTHR) announced it acquisition of all of the outstanding equity of IVIVA Medical, Inc., a...
Nature’s Toolbox’s $47.5 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Nature’s Toolbox on the transaction. Nature’s Toolbox (NTx) announced the close of a $47.5 million Series B funding round led by...
Neuvivo’s $11 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised Neuvivo in the deal. Neuvivo announced that it has closed an $11 million round of financing led by PrimeStreet Capital. The funding will...
Spring Free EV’s $31 Million Fundraise
Wilson Sonsini Goodrich & Rosati advised Spring Lane Capital on the deal. Spring Free EV, a financial technology company accelerating the adoption of electric vehicles (EVs)...
Cognito Therapeutics’ $73 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Cognito on the transaction. Neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led...
ATP’s Launch of Ascidian Therapeutics
Wilson Sonsini Goodrich & Rosati advised Ascidian Therapeutics on the deal. Life sciences venture capital firm ATP announced the launch of new biotechnology company Ascidian Therapeutics....